The anti-diabetes drug insulin is the subject of many false beliefs and misconceptions, when in fact, it may well be one of the most notable medical innovations in the past hundred years. The discovery of the insulin molecule in 1921 ignited a century of groundbreaking innovations that saved lives and ultimately gave hope to patients living with diabetes.
From the first type of insulin, to the first longer-acting variant, and more innovations, novel types of insulin have now become available to patients, giving them more freedom and flexibility to work with their doctors in the management of their disease.The use of insulin is not indicative of an end-stage severe disease. Research study shows that an early start with insulin can prevent possible complications. In the recent study done in 6 countries including Philippines, patients who were started on co-formulation insulin from oral medications had a decrease of HbA1c by 2%, denoting better glucose control with insulin therapy, and thereby, better disease control of diabetes.
Insulin does not indicate a severe case of diabetes. It provides a better option to control it.
There is also a common myth that insulin is dangerous. However, the truth is that insulins used today acts in a very similar way to those made by the body. And while nobody likes getting shots, most people are surprised how little an insulin injection hurts as its needles are very thin and small. Medical innovations and new treatments are being done to make insulin injectable less painful such as fine needle features which can enhance flow rates and reduce dosage force.
The second most common reason for initiating or switching to insulin among Filipino physicians is its flexibility in dosing regimen, based on the study. Co-formulation insulin can be flexibly given at the biggest meal of the day and can lessen injection burden by having 2 insulins in 1 pen.
Diabetes care is Novo Nordisk’s focus. As a trusted healthcare partner, Novo Nordisk is one with the Filipino family in defeating diabetes through proper information, timely health management and medical innovation.
This year, Novo Nordisk launched its Insulin 100 campaign to showcase the remarkable discovery of insulin and its continuous development to give hope to patients living with diabetes.
“In the next 100 years, we are committed to not only expanding access but also prevent and maybe cure diabetes,” shared Cihan Serdar Kızılcık, Vice-President and General Manager, Novo Nordisk Philippines.
With this year’s commemoration, Novo Nordisk demonstrates that its past honors its commitment to fighting diabetes and even going beyond medical innovation for years to come.
